AKT1 and gastric cancer: In MDR gastric cancer cells, estradiol cypionate reduces AKT protein expression by increasing ubiquitination, thereby inhibiting the overactivation of the PI3K-AKT-mTOR signaling pathway and suppressing cell growth [117].